Peer Review History

Original SubmissionDecember 27, 2020
Decision Letter - Henk D. F. H. Schallig, Editor

PONE-D-20-37870

Development of a Multiplex Loop-Mediated Isothermal Amplification (LAMP) Assay for On-Site Diagnosis of SARS CoV-2

PLOS ONE

Dear Dr. Lim,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

In particular it is requested to increase your sample size and provide a sample size calculation for this study. Increasing the number of samples/patients and including more non-Covid cases would make this manuscript acceptable.

Please submit your revised manuscript by Feb 26 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Henk D. F. H. Schallig, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript describes (another) development and evaluation of a LAMP assay for Covid19. There are many publications describing such a test (see list below). Consequently the authors should make clear why their test has an add on value.

Although the work is well designed and presented, a concern is that the sample size is rather limited. A sample size calculation is not provided. This must be done.

The paper would stand out amongst all other papers in this particular field if they would have assesses a much larger sample size. This is not the case. Therefore, I recommend that the authors should extend their study population before re-submitting the manuscript.

A non-template control should be included in the assay.

The resolution of figure 2 is rather low.

Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19.

Kashir J, Yaqinuddin A.Med Hypotheses. 2020 Aug;141:109786. doi: 10.1016/j.mehy.2020.109786. Epub 2020 Apr 25.PMID: 32361529 Free PMC article.

Loop-Mediated Isothermal Amplification (LAMP): A Rapid, Sensitive, Specific, and Cost-Effective Point-of-Care Test for Coronaviruses in the Context of COVID-19 Pandemic.

Augustine R, Hasan A, Das S, Ahmed R, Mori Y, Notomi T, Kevadiya BD, Thakor AS.Biology (Basel). 2020 Jul 22;9(8):182. doi: 10.3390/biology9080182.PMID: 32707972 Free PMC article.

A Rapid, Simple, Inexpensive, and Mobile Colorimetric Assay COVID-19-LAMP for Mass On-Site Screening of COVID-19.

Chow FW, Chan TT, Tam AR, Zhao S, Yao W, Fung J, Cheng FK, Lo GC, Chu S, Aw-Yong KL, Tang JY, Tsang CC, Luk HK, Wong AC, Li KS, Zhu L, He Z, Tam EWT, Chung TW, Wong SCY, Que TL, Fung KS, Lung DC, Wu AK, Hung IF, Woo PC, Lau SK.Int J Mol Sci. 2020 Jul 29;21(15):5380. doi: 10.3390/ijms21155380.PMID: 32751106 Free PMC article.

Rapid Detection of COVID-19 Coronavirus Using a Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) Diagnostic Platform.

Yu L, Wu S, Hao X, Dong X, Mao L, Pelechano V, Chen WH, Yin X.Clin Chem. 2020 Jul 1;66(7):975-977. doi: 10.1093/clinchem/hvaa102.PMID: 32315390 Free PMC article.

RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2.

Huang WE, Lim B, Hsu CC, Xiong D, Wu W, Yu Y, Jia H, Wang Y, Zeng Y, Ji M, Chang H, Zhang X, Wang H, Cui Z.Microb Biotechnol. 2020 Jul;13(4):950-961. doi: 10.1111/1751-7915.13586. Epub 2020 Apr 25.PMID: 32333644 Free PMC article.

Use of the variplex™ SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis.

Rödel J, Egerer R, Suleyman A, Sommer-Schmid B, Baier M, Henke A, Edel B, Löffler B.J Clin Virol. 2020 Nov;132:104616. doi: 10.1016/j.jcv.2020.104616. Epub 2020 Aug 31.PMID: 32891938 Free PMC article.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Reviewer #1:

1. This manuscript describes (another) development and evaluation of a LAMP assay for Covid19. There are many publications describing such a test (see list below). Consequently the authors should make clear why their test has an add on value.

Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19. Kashir J, Yaqinuddin A.Med Hypotheses. 2020 Aug;141:109786. doi: 10.1016/j.mehy.2020.109786. Epub 2020 Apr 25.PMID: 32361529 Free PMC article.

Loop-Mediated Isothermal Amplification (LAMP): A Rapid, Sensitive, Specific, and Cost-Effective Point-of-Care Test for Coronaviruses in the Context of COVID-19 Pandemic. Augustine R, Hasan A, Das S, Ahmed R, Mori Y, Notomi T, Kevadiya BD, Thakor AS.Biology (Basel). 2020 Jul 22;9(8):182. doi: 10.3390/biology9080182.PMID: 32707972 Free PMC article.

A Rapid, Simple, Inexpensive, and Mobile Colorimetric Assay COVID-19-LAMP for Mass On-Site Screening of COVID-19. Chow FW, Chan TT, Tam AR, Zhao S, Yao W, Fung J, Cheng FK, Lo GC, Chu S, Aw-Yong KL, Tang JY, Tsang CC, Luk HK, Wong AC, Li KS, Zhu L, He Z, Tam EWT, Chung TW, Wong SCY, Que TL, Fung KS, Lung DC, Wu AK, Hung IF, Woo PC, Lau SK.Int J Mol Sci. 2020 Jul 29;21(15):5380. doi: 10.3390/ijms21155380.PMID: 32751106 Free PMC article.

Rapid Detection of COVID-19 Coronavirus Using a Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) Diagnostic Platform. Yu L, Wu S, Hao X, Dong X, Mao L, Pelechano V, Chen WH, Yin X.Clin Chem. 2020 Jul 1;66(7):975-977. doi: 10.1093/clinchem/hvaa102.PMID: 32315390 Free PMC article.

RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2. Huang WE, Lim B, Hsu CC, Xiong D, Wu W, Yu Y, Jia H, Wang Y, Zeng Y, Ji M, Chang H, Zhang X, Wang H, Cui Z.Microb Biotechnol. 2020 Jul;13(4):950-961. doi: 10.1111/1751-7915.13586. Epub 2020 Apr 25.PMID: 32333644 Free PMC article.

Use of the variplex™ SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis. Rödel J, Egerer R, Suleyman A, Sommer-Schmid B, Baier M, Henke A, Edel B, Löffler B.J Clin Virol. 2020 Nov;132:104616. doi: 10.1016/j.jcv.2020.104616. Epub 2020 Aug 31.PMID: 32891938 Free PMC article.

-> As you mention above, all case of SARS CoV-2 RT-LAMP assay showed good performance. However, they used one reaction mixture in one tubes for detecting one gene of SARS CoV-2. Thus, for detecting two gene of SARS CoV-2 and internal control gene in order to increase sensitivities, they need at least three reaction tubes. Furthermore, it is known that LAMP assay is easy to contaminate. So, our multiplex LAMP assay in one tube have advantages for reducing test time and risk of contamination. These contents were included in discussion following as:

“Currently, several SARS CoV-2 LAMP primer sets were reported [23-26]. They were mostly developed with fast colorimetric detection of one or two genes suitable for on-site diagnosis [27-30]. However, it has disadvantages in not producing diagnose with multiplex testing and having to test each primer set individually. In particular, the LAMP assay has been reported to be highly susceptible to contamination [31, 32], and the recently reported SARS CoV-2 RT-LAMP assay has also pointed out such a problem [33]. Therefore, if an RT-LAMP test for one clinical sample is performed with three or four LAMP primer sets (including internal control) individually, the degree of contamination may also increase. In addition, when conducting clinical tests in large quantities, the number of clinical trials more than doubles, and the advantage of a rapid diagnosis of the LAMP assay may be diluted. Therefore, the multiplex SARS CoV-2 RdRP/N/IC RT-LAMP assay developed in this study has an advantage in minimizing the contamination and enabling a mass diagnosis.” (line 263-274)

2. Although the work is well designed and presented, a concern is that the sample size is rather limited. A sample size calculation is not provided. This must be done.

-> We added sentence based on the comment following as:

“To estimate the number of samples required for clinical test of the multiplex RT-LAMP assay, the following formula was used:

n≥(〖(1.96)〗^2 p(1-p))/x^2

where p is the suspected sensitivity, and x is the desired margin of error [15, 16]. The true-positive rate (sensitivity) was defined as the proportion of SARS-CoV-2 positive which is correctly identified by the multiplex RT-LAMP assay compared to the AllplexTM 2019-nCoV Assay (Seegene, Inc., Seoul, South Korea). We suspected the sensitivity and specificity of the multiplex RT-LAMP assay to be 95% with a desired margin of error of 0.04%. Under these conditions, the number of required samples is 114.0475 (rounded up to 115) per group. In this experiment, we have tested total 292 samples (130 positive and 162 negative).” (Line 92-101)

3. The paper would stand out amongst all other papers in this particular field if they would have assesses a much larger sample size. This is not the case. Therefore, I recommend that the authors should extend their study population before re-submitting the manuscript.

-> As your suggestion, we assess the multiplex LAMP assay with 293 clinical samples (130 SARS CoV-2 samples and 162 negative samples.

4. A non-template control should be included in the assay.

-> We have added the non-template control in Figure 1 Legend based on the comment following as:

“Numbers (1-10) indicated plasmid copy numbers/μL (1.0 × 108 - 1.0 × 100 copies/μL) and negative control (distilled water (DW) as non-template control).” (Line 474-475)

5. The resolution of figure 2 is rather low.

-> We have corrected the resolution of figure 2 based on the comment.

Attachments
Attachment
Submitted filename: Response to Reviewers_SARS CoV-2 v7.docx
Decision Letter - Henk D. F. H. Schallig, Editor

Development of a Multiplex Loop-Mediated Isothermal Amplification (LAMP) Assay for On-Site Diagnosis of SARS CoV-2

PONE-D-20-37870R1

Dear Dr. Lim,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Henk D. F. H. Schallig, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Well revised! Clear sample size estimation and it is noted what the advantage of this approach is compared to other assays

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Formally Accepted
Acceptance Letter - Henk D. F. H. Schallig, Editor

PONE-D-20-37870R1

Development of a Multiplex Loop-Mediated Isothermal Amplification (LAMP) Assay for On-Site Diagnosis of SARS CoV-2

Dear Dr. Lim:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Henk D. F. H. Schallig

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .